Home/Specialties/ENT & Otolaryngology Surgery

Practice · ENT & Otolaryngology Surgery

The referral engine your ENT OT calendar needs.

We build GP, paediatrician and audiologist pathways for FESS sinus, cochlear implant, thyroid, tonsillectomy and complex head-and-neck programmes.

For Chiefs of ENT, Otology Program Directors and MDs of super-specialties with dedicated ENT units.

Request a ENT Pipeline Blueprint →Review case evidence

GP Referral MOUs

signed in metro catchment

Cochlear Implant Volume

+186%

12-month cohort

FESS Case Volume

+142%

9-month cohort

OT Utilization

80%

ENT block

Procedure-level demand engineering

We target the procedures that move your P&L, not the ones that fill the OPD queue.

CATCHMENT TIER · PRICE RESTATEMENT

ARPU differs materially between Metro, Tier-2 and Tier-3 catchments. Switch tier to restate every procedure band against the payer mix and package ceilings we observe in that market — not a single all-India number.

Viewing Metro / Tier-1 · Representative catchments: Delhi NCR, Mumbai, Bengaluru, Chennai, Hyderabad, Kolkata, Pune.

FESS Sinus Surgery

₹1.2 L–2.4 L

Chronic-sinusitis conversion funnel

Cochlear Implant

₹6.0 L–14 L

Paediatric audiology referral funnel

Thyroidectomy

₹1.4 L–3.2 L

Nodule-workup surgical pathway

Tonsillectomy / Adenoidectomy

₹40K–1.2 L

Paediatrician day-care funnel

Head & Neck Onco (with Onco)

₹3.5 L–8.0 L

Biopsy-report MDT funnel

Otoplasty & Stapedectomy

₹1.4 L–2.8 L

Long-cycle premium referral

Methodology. Base bands reflect RDV's engagement dataset across 47 super-specialty hospitals, reconciled against CGHS/ECHS package rates, state-scheme ceilings (Ayushman Bharat PM-JAY, CMCHIS, YSR Aarogyasri) and empanelled TPA grids. Tier multipliers applied: Metro 1.00× · Tier-2 0.72× · Tier-3 0.55×. Actuals swing with payer mix, consultant-fee split and implant/consumable choice — the written Blueprint restates every band against your own HIS billing history before any spend is committed.

Clinical referral pathway

Intent → triage → consult → admission. Instrumented at every gate.

01 · Intent capture
Symptom, condition and referrer-based intent capture across catchment.
02 · Clinical triage
Specialty-trained nurse/coordinator triage with report upload before consult.
03 · Consultant handoff
Calendar-synced booking to the operating consultant with pre-read notes.
04 · Admission & OT slotting
CRM ↔ HIS tag: admission source, procedure code, OT date.

Case snapshot

2.4× surgical volume, 84 GP referral MOUs signed.

A representative RDV engagement in the ENT & Otolaryngology Surgery practice line. Individual results vary by catchment, clinical capacity and payer mix.

Setting: ENT unit inside multi-specialty tertiary, 40 beds
Duration: 10 months
Cohort: n = 1,180 GP-referred cases
Outcome: 2.4× surgical volume, 84 GP referral MOUs signed

Figures engagement-verified against hospital HIS. No outcome guarantees implied; per NMC advertising guidelines.

Why Chiefs of ENT choose RDV

Trust is earned in the operating logic, not the pitch deck.

GP referrer primacy

ENT growth flows through GPs and paediatricians. Signed MOU network is the primary demand engine.

Audiologist-network cochlear funnel

Cochlear implant demand built through audiologist and speech-therapy referral networks — never through direct device marketing.

Chronic-sinusitis medical-first triage

Every FESS enquiry medically triaged; only failed-medical-management candidates proceed to surgical consult.

State-scheme integration

Cochlear implant volume amplified through state-scheme (ADIP) enrolment workflows — public-good positioning that generates private-referral trust.

From an engagement

"Our cochlear programme doubled in a year without touching device-brand messaging. The audiologist MOU network did all the work."

— Chief of ENT & Otology · 40-bed multi-specialty tertiary

Attribution anonymised per client confidentiality; engagement code verifiable in the founder-led review.

Talk directly to the founding partner who ran this engagement.

Request a ENT Blueprint →

48-hour founder-led review. Fixed-scope. No lock-in.

Clinical authority

Content your clinicians will co-sign.

ENT surgeon FESS technique & recovery library
Audiologist + ENT cochlear-candidate decision framework
Head-and-neck onco MDT (ENT + onco + radiotherapy) protocol

Compliance posture

Every asset, every claim, medically reviewed.

NMC norms — no comparative outcome claims
DCGI compliance for cochlear device messaging
Paediatric-consent workflow for tonsillectomy and cochlear

Catchment note: Metropolitan GP-network engineering with paediatrician overlap; state-level cochlear-implant scheme integration.

The 21-day diagnostic

What the fixed-scope engagement actually contains — for ENT.

No mystery, no scope creep. Each week is instrumented and delivered against a checklist your MD and Chief signs.

Week 1
ENT OT audit; procedure-mix and referral-source teardown.
Week 2
GP, paediatrician and audiologist referrer catchment mapping.
Week 3
Procedure economics; state-scheme cochlear model.
Week 4
Founder-led blueprint with Chief of ENT.

Where we compound

The unfair edge — for ENT specifically.

GP + paediatrician + audiologist tri-network unique in category
State-scheme cochlear integration workflow operational
Medical-first FESS triage prevents inappropriate surgical push

Practice guarantees

What we commit to in writing.

Fixed-scope diagnostic — no retainer, no annual lock-in
HIS-verified attribution — every claimed admission traceable to source
No media markup — you see raw platform invoices at cost
Founder-led — the partner who scopes the engagement does the work

Objections we hear

The three questions MDs ask before signing.

We keep our answers on the record. If yours isn't here, ask it in the qualification form — the founding partner replies personally within 48 hours.

ENT is a low-margin specialty.

In aggregate — but cochlear, thyroid and head-neck onco are high-yield lines. We over-index the funnel on those.

Cochlear device advertising is regulated.

Correct. We don't do device advertising. We build audiologist-referral networks that generate demand upstream of the device decision.

Our GP network is thin.

Then that's the primary deliverable of the diagnostic phase. GP MOUs are a build-once, compound-forever asset.

FAQ

The questions Chiefs of ENT ask us first.

If yours isn't here, put it in the qualification form — our founding partner will answer it in the 48-hour review.

How do you build GP referral networks?+

District by district with a documented value exchange: outcome-tracking dashboards, joint patient-education content and CME sponsorship.

Can cochlear be marketed compliantly?+

Not as a device. As a hearing-restoration clinical pathway, audiologist-referred, with DCGI-safe framing. That's the only way we build it.

What about state-scheme cochlear?+

We integrate your programme into ADIP and state-scheme enrolment workflows — visible public-good work that generates disproportionate private-referral trust.

Next step